These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 36810081

  • 1. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
    Peng B, Hu Q, He R, Hou H, Lian D, Chen Y, Li H, Song L, Gao Y, Chen T, Zhang G, Li J.
    BMC Complement Med Ther; 2023 Feb 21; 23(1):62. PubMed ID: 36810081
    [Abstract] [Full Text] [Related]

  • 2. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y, Zhao C, Lei L, Tao Z, Zheng L, Wen J, Li X.
    Int J Rheum Dis; 2020 Mar 21; 23(3):406-419. PubMed ID: 31840939
    [Abstract] [Full Text] [Related]

  • 3. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models.
    Zhang Z, Wu Y, Wu B, Qi Q, Li H, Lu H, Fan C, Feng C, Zuo J, Niu L, Tang W.
    Arthritis Res Ther; 2019 Dec 16; 21(1):290. PubMed ID: 31842999
    [Abstract] [Full Text] [Related]

  • 4. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE.
    Arthritis Res Ther; 2013 Oct 28; 15(5):R168. PubMed ID: 24289101
    [Abstract] [Full Text] [Related]

  • 5. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
    Xie X, Gan H, Tian J, Li F, Chen J, Wang J, Liao J, Li S.
    Eur J Clin Invest; 2022 Aug 28; 52(8):e13791. PubMed ID: 35441708
    [Abstract] [Full Text] [Related]

  • 6. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
    Jiang Y, Hu F, Li M, Li Q.
    Clin Exp Pharmacol Physiol; 2024 Feb 28; 51(2):e13834. PubMed ID: 38037494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A.
    Arthritis Rheum; 2013 May 28; 65(5):1378-83. PubMed ID: 23436317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L, Song Y, Li M.
    J Dermatol Sci; 2015 Jan 28; 77(1):63-70. PubMed ID: 25465161
    [Abstract] [Full Text] [Related]

  • 13. Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression.
    Ji-Hong Y, Yu M, Ling-Hong Y, Jing-Jing G, Ling-Li X, Lv W, Yong-Mei J.
    Pharm Biol; 2023 Dec 28; 61(1):288-297. PubMed ID: 36815239
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX3 CL1/CX3 CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis.
    Luong VH, Utsunomiya A, Chino T, Doanh LH, Matsushita T, Obara T, Kuboi Y, Ishii N, Machinaga A, Ogasawara H, Ikeda W, Kawano T, Imai T, Oyama N, Hasegawa M.
    Arthritis Rheumatol; 2019 Nov 28; 71(11):1923-1934. PubMed ID: 31173491
    [Abstract] [Full Text] [Related]

  • 15. Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models.
    Shen Z, Su T, Chen J, Xie Z, Li J.
    Ann Transl Med; 2021 May 28; 9(9):801. PubMed ID: 34268414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.
    Wu T, Chu H, Tu W, Song M, Chen D, Yuan J, Yu L, Ma Y, Liu Q, Jin L, Zhou X, Zou H, Wu W, Wang J.
    BMC Complement Altern Med; 2014 Jul 07; 14():224. PubMed ID: 24998426
    [Abstract] [Full Text] [Related]

  • 18. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
    Kajii M, Suzuki C, Kashihara J, Kobayashi F, Kubo Y, Miyamoto H, Yuuki T, Yamamoto T, Nakae T.
    Clin Exp Immunol; 2011 Feb 07; 163(2):235-41. PubMed ID: 21091669
    [Abstract] [Full Text] [Related]

  • 19. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.
    Arthritis Rheum; 2010 Aug 07; 62(8):2476-87. PubMed ID: 20506342
    [Abstract] [Full Text] [Related]

  • 20. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L, Yang M, Tian X, Zhao P, Mei X, Bai Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov 07; 34(11):1161-1166. PubMed ID: 36567559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.